Pfizer, BioNTech get vaccine ‘fast track’ from FDA

Pfizer Inc and partner BioNTech SE said two of their experimental coronavirus vaccines received ‘fast track’ designation from the U.S. Food and Drug Administration, speeding up the regulatory review process.


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:

Leave a Comment